Clinical trial · Interventional
Inositol Treatment in Different Type of PCOS Phenotype
The Effect of Inositol Treatment in Women With PCOS of Different Phenotype
NCT05678114CI-TRIAL-00066473completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of the efficacy of inositol treatment in women with PCOS in relation to the phenotype (according to the Rotterdam Criteria)
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Myo-inositol | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Hyperandrogenic PCOS
- interventionNames
- Dietary Supplement: Myo-inositol
- type
- EXPERIMENTAL
- label
- Non-hyperandrogenic PCOS
- interventionNames
- Dietary Supplement: Myo-inositol
Primary outcomes (1)
- measure
- Regularization of the menstrual cycle
- timeFrame
- Change from baseline number of women with irregular menstrual cycle at 4 months
- description
- Number of women with regular/altered menstrual cycle
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * women with PCOS of any phenotype Exclusion Criteria: * hormonal treatment (such as contraceptive pill) * use of supplements containing myo-inositol * severe co-morbidities
References
Publications (0)
Data not yet available
No reference posted for this study.